Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures

http://www.wormdigest.org/component/option,com_banners/task,click/bid,73/
Any determinations regarding the convertibility of the Debentures durinhg future periods will be made in accordancee with the terms of the indenturwe under which the Debentures wereissued (the The Debentures became convertible because the last reporte sale price of Allscripts common stock for at leasyt 20 consecutive trading days within the 30-trading-dauy period ending on May 29, 2009 was greatet than 130 percent of the conversion pric e in effect on May 29, 2009. As a during the conversion period, holders of the Debenturesw may convert the Debentures into shares of common subject to the terms ofthe Indenture.
Pursuangt to the terms of the Indenture, the Debentures are convertible at the conversion rateof 124.3781 shares per $1,000 principal amountf of each Debenture. Allscripts has the right to satisfy the conversionj with cash in lieu of sharez of common stock in accordancs with the terms ofthe Additionally, Allscripts announced today pursuant to the terms of the Indenture, holdersa of Debentures have the righty to require Allscripts to repurchase theit Debentures (the "Repurchase Right") for cash in an amount equall to 100 percent of the principapl amount of the Debentures ($1,000 per each $1,00 0 principal amount outstanding) plus accrued and unpaid interest and Liquidatedx Damages (as defined in the Indenture) to, but excluding, July 15, 2009.
The Repurchase Right is subject to the terms and conditionss described in the Notice of Right to Require Repurchasd sent to Debenture holders and the The Repurchase Right will expireat 5:00 p.m., Easterj Daylight Time, on July 15, 2009. In order to surrenderd Debenturesfor purchase, a purchased notice must be delivered to Wilmington Trust FSB, as successodr trustee and paying agent to LaSallee Bank N.A., or through The Depository Trus t Company by 5:00 Eastern Daylight Time, on July 15, 2009. Holders may withdrawe any Debentures previously surrendered for purchase at any time priotrto 5:00 p.m.
, Eastern Daylight Time, on July 15, 2009 by deliveringb a notice of withdrawal to the payintg agent at the address listed in the Noticre of Right to Require Repurchase or through the Depositoryg Trust Company. Debenture holders are urgede to consult their tax advisor regardingf the tax consequences ofthe foregoing. Allscripts (Nasdaq: uses innovation technology to bring healthto healthcare. More than 150,00p physicians, 700 hospitals and nearly 7,000 post-acutr and homecare organizations utilize Allscripts to improvde the health of their patients and theirdbottom line.
The company's award-winning solutiond include electronichealth records, electronic prescribing, revenue cycle practice management, document management, medication services, hospital care management, emergency department information systemz and homecare automation. Allscripts is the brand name of Allscripts-Misyds Healthcare Solutions, Inc. To learn more, visit . This news releasw may contain forward-looking statements within the meaninfg of the federal securities Statements regardingfuture events, developments, the Company'a future performance, as well as management's expectations, intentions, plans, estimates or projections relating to the futurse are forward-looking statements within the meaning of these laws.
Thesr forward-looking statements are subject to a number of riskdsand uncertainties, some of which are outlined As a result, actual results may vary materiallyt from those anticipated by the forward-looking Among the important factors that coulc cause actual results to diffe r materially from those indicated by such forward-looking statementas are: the volume and timing of systemds sales and installations; length of salexs cycles and the installation process; the possibility that product will not achieve or sustain market acceptance; the cost and success or failur of new product and service introductions, developmen t and product upgrade releases; competitive pressures includinfg product offerings, pricing and promotional our ability to establish and maintain strategic relationships; undetecte d errors or similar problems in our softwarse products; compliance with existing laws, regulationsd and industry initiatives and future changes in laws or regulationsw in the healthcare industry; possible regulation of the Company's softwaree by the U.
S. Food and Drug Administration; the possibilith of product-related liabilities; our abilityy to attract and retainqualified personnel; our ability to identify and completwe acquisitions, manage our growth and integratee acquisitions; the ability to recognize the benefits of the merger with Misyx Healthcare Systems, LLC the integration of MHS with the Company and the possibled disruption of current plana and operations as a result maintaining our intellectual propertuy rights and litigation involving intellectuaol property rights; risks relatedc to third-party suppliers; our ability to use or successfully integrate third-party licensed technology; breach of our securitgy by third parties; and the risk factores detailed from time to time in our reports filed with the Securitiews and Exchange Commission, including our 2007 Annual Report on Form 10-K availablw through the Web site maintained by the Securities and Exchange Commissionn at .
The Company undertakes no obligation to updatr publiclyany forward-looking statement, whether as a resul t of new information, future events or